Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
LeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares Outstanding
Ratios

Ping An Biomedical (PASW) Receivables - Net (2024 - 2025)

Ping An Biomedical filings provide 2 years of Receivables - Net readings, the most recent being $2.4 million for Q3 2025.

  • On a quarterly basis, Receivables - Net fell 67.07% to $2.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was $2.4 million, a 67.07% decrease, with the full-year FY2025 number at $4.5 million, down 37.24% from a year prior.
  • Receivables - Net hit $2.4 million in Q3 2025 for Ping An Biomedical, up from $1.4 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $7.2 million in Q3 2024 to a low of -$1.8 million in Q1 2024.